[{"name":"Summary and Conclusion (ID 773)","mode":"","is_cme":false,"info":{"presentation":"Summary and Conclusion <small>(ID 773)<\/small>","session":"MSD - Industry Satellite Symposium: The evolving treatment landscape of early triple negative breast cancer <small>(ID 74)<\/small>","presenter":"Sherko Kümmel<small> (Essen, Germany)<\/small>","photo":null},"playlist":[{"name":"Summary and Conclusion","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/74\/v\/773_3c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/74\/v\/773_3c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/74\/v\/773_3c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/74\/v\/773_3c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"9L240ek02Vk"}